Equities

Gabelli Healthcare & WellnessRx Trust

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GRX:NYQ

Gabelli Healthcare & WellnessRx Trust

Actions
FinancialsClosed End Investments
  • Price (USD)9.72
  • Today's Change-0.10 / -1.02%
  • Shares traded50.40k
  • 1 Year change-3.38%
  • Beta0.8887
Data delayed at least 15 minutes, as of Feb 17 2026 18:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

The Gabelli Healthcare and WellnessRx Trust (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is long term growth of capital. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. It invests in various sector, such as beverages, biotechnology, electronics, equipment and supplies, food, health care providers and service, household and personal products, and pharmaceuticals. The Fund’s investment adviser is Gabelli Funds, LLC.

  • Revenue in USD (TTM)3.76m
  • Net income in USD-704.42k
  • Incorporated2007
  • Employees--
  • Location
    Gabelli Healthcare & WellnessRx TrustOne Corporate CenterRYE 10580-1422United StatesUSA
  • Phone+1 (914) 921-5100
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oxford Square Capital Corp40.14m-2.56m147.82m0.00--0.93--3.68-0.0351-0.03510.55121.950.1279--10.31---0.8172-1.22-0.8274-1.2368.1862.54-6.39-10.03--0.90610.4878---17.64-7.39-65.89------
Nuveen Arizona Premium Income Mun Fd-100.00bn-100.00bn148.30m--------------------------------------------------------------
AA Mission Acquisition Corp II-100.00bn-100.00bn148.38m-----------------0.0083--------------------------------------------
BlackRock MuniYield Pennsylvan Qulty Fnd-100.00bn-100.00bn148.92m--------------------------------------------------------------
Indigo Acquisition Corp-100.00bn-100.00bn149.03m2.00--1.32----------7.66----------------------------0.00--------------
ACC Aviation Holdings Ltd0.00-2.77m149.68m0.00---------0.2318-0.23180.00-0.02220.00-------562.67---1,221.27-------------84.513.31------19.77------
Gabelli Healthcare & WellnessRx Trust3.76m-704.42k151.70m----0.927--40.33-0.0456-0.04560.243410.590.0176--2.15---0.32881.41-0.32991.43-46.26-38.87-18.73103.63----0.169332.20-4.05-0.6463-167.41----1.39
WhiteHorse Finance Inc76.34m9.86m152.24m--15.440.574--1.990.42420.42423.2811.410.1166--33.48--1.512.901.593.0043.8647.1812.9126.05--1.560.5495162.63-10.116.71-46.84-18.85--1.64
Voya Global Advantage and Prem Oppty Fd4.94m18.00m152.95m--8.500.9522--30.991.171.170.321710.470.0303--1.89--11.067.8611.107.9170.6871.18364.80254.42----0.00102.52-13.33-7.01114.87----6.05
Clough Global Equity Fund-100.00bn-100.00bn153.37m----------------------------1.27--1.46---51.05--90.26------524.48-22.43-5.63-12.9217.43---10.22
Credit Suisse Asset Management In FndInc17.79m13.96m153.78m6.0011.180.955--8.650.25090.25090.322.940.0758--3.33--5.953.796.383.9676.4882.3678.4954.45----0.2812160.571.361.14-42.38-11.92--0.00
Perceptive Capital Solutions Corp0.002.42m153.95m--65.851.75----0.21120.21120.007.930.00------2.67--2.69--------------0.00--------------
Flaherty & Crumrn Prfrd and Incm Fnd Inc-100.00bn-100.00bn154.42m0.00------------------------------------------------------------
Western Asset Municipal Hgh Incm Fnd Inc-100.00bn-100.00bn155.23m--------------------------------------------------------------
Lafayette Acquisition Corp-100.00bn-100.00bn156.35m-----------------0.0055----------------------------1.61--------------
Data as of Feb 17 2026. Currency figures normalised to Gabelli Healthcare & WellnessRx Trust's reporting currency: US Dollar USD

Institutional shareholders

30.35%Per cent of shares held by top holders
HolderShares% Held
Saba Capital Management LPas of 17 Dec 20252.12m13.41%
Sit Investment Associates, Inc.as of 31 Dec 20251.03m6.53%
GAMCO Asset Management, Inc.as of 12 Jan 2026322.41k2.04%
Blue Bell Private Wealth Management LLCas of 31 Dec 2025292.67k1.85%
LPL Financial LLCas of 31 Dec 2025291.56k1.85%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025199.62k1.26%
Aviance Capital Partners LLCas of 31 Dec 2025167.84k1.06%
Wells Fargo Clearing Services LLCas of 31 Dec 2025139.28k0.88%
Stephens Investment Management Group LLCas of 31 Dec 2025121.04k0.77%
Wells Fargo Advisors Financial Network LLCas of 31 Dec 2025111.55k0.71%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.